The Oversight Board’s judgment comes in the midst of a new study published in the American Journal of Medicine (AJM) which confirmed positive results for early treatments of COVID-19 using HCQ, and supported early outpatient treatment with this medication.
‘The board’s decisions to uphold or reverse Facebook’s content decisions will be binding, meaning that Facebook will have to implement them, unless doing so could violate the law’
By Patrick Delaney Tue Feb 2, 2021 – 10:30 am EST
MENLO PARK, California, February 2, 2021 (LifeSiteNews) — Facebook’s new oversight board has overturned the tech giant’s decision to censor a post promoting the use of hydroxychloroquine (HCQ) as a treatment for COVID-19. The social media platform removed the post last year, saying that it causeda “risk of offline harm” due to “misinformation.”
The corporation’s oversight board was created last year to act as a kind of supreme court adjudicating difficult censorship cases. The board’swebsitestates its role is to use “its independent judgment to support people’s right to free expression and ensure those rights are being adequately respected.”
Furthermore, the “board’s decisions to uphold or reverse…
View original post 932 more words